Frédéric GAGNADOUX
Angers, 49933, France
NCT Number: NCT04459182
Evaluation of miRNA contained in exosomes in obese and OSA patients with endothelial dysfunction evaluated by digital plethysmography (ENDOPAT) compared to obese and OSA patients without endothelial dysfunction.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Angers, 49933, France
The aim of the study is to compare the content of exosomes between two goups of 20 patients, with and without endothelial dysfucntion.
the endothelial function will be evaluated after polysomnography, on obese patients with OSA (AHI >15).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
digital plethysmography
Time frame: immediately after the consultation
compare exosome content between obese-OSA patients with endothelial dysfunction and without
University Hospital, Angers
Other Gov
Circulating Exosomes and Endothelial Dysfunction in Patients With Obstructive Sleep Apneas Hypopneas Syndrome(OSA): EXODYS
Acronym: EXODYS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03778307
Endothelial Dysfunction, Mental Disorders
Los Angeles, California, United States
View Trial DetailsNCT06472791
Endothelial Dysfunction
Portland, Oregon, United States
View Trial DetailsNCT07569744
Diabetes Mellitus, Diabetes Mellitus, Type 2
Palembang, South Sumatera, Indonesia
View Trial DetailsNCT05107869
Cardiovascular Diseases, Endothelial Dysfunction
Wauwatosa, Wisconsin, United States
View Trial Details